Immune outcomes with dolutegravir‐based dual therapy versus bictegravir‐based triple therapy: A multinomial propensity score analysis

Jesús Troya, Guillermo Pousada, Ignacio de los Santos, Rafael Micán, Carlos Galera, José Sanz, Alberto Díaz de Santiago, José Antonio Iribarren, Estela Moreno, Miguel Ángel Morán, Julia Gómez, Pepa Galindo, Cristina Martín, Carlos Dueñas, Luis Buzón‐Martín
HIV Medicine · Wiley · 2026-11-13 · DOI: 10.1111/hiv.70365

Abstract

Abstract Objectives To compare immune outcomes after switching to dolutegravir/lamivudine (DTG/3TC), dolutegravir/rilpivirine (DTG/RPV) and bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF). Methods Three Spanish cohorts of adults with baseline HIV‐RNA <50 copies/mL were harmonized. Multinomial propensity scores were used for 13 baseline variables. Stabilized inverse probability weights were winsorized at the 1st/99th percentiles. The primary outcome was baseline‐adjusted CD4+ T‐cell count at week 48. Bootstrap confidence intervals and Holm's correction were used. Results Of 3057 eligible participants, 1794 had complete covariates and 1438 had week‐48 CD4+ T‐cell counts. B/F/TAF versus DTG/3TC and DTG/RPV differences were −7.4 (95% CI −45.1 to 30.4) and +5.6 (−24.6 to 35.7) cells/μL (both Holm p = 1.000). Additional baseline CD4+ T‐cell percentage adjustment changed the former to −39.8 (−78.5 to −1.2). CD4+ T‐cell percentage differences were + 1.66 and + 1.44 percentage points (both Holm p ≤ 0.002). Original secondary CD8+ T‐cell count differences were − 92.9 and − 96.5 cells/μL (both Holm p = 0.007); the ratio difference versus DTG/3TC was +0.165 (Holm p = 0.013). Conclusions In these three Spanish cohorts, the primary propensity score‐adjusted analysis did not detect a difference between regimens in the week‐48 CD4+ T‐cell count. Original secondary analyses associated B/F/TAF with lower CD8+ T‐cell counts than both dual regimens and a higher CD4+/CD8+ T‐cell ratio than that of DTG/3TC. The CD8+ T‐cell count and ratio contrasts versus DTG/3TC attenuated after additional baseline percentage adjustment. These associations were sensitive to baseline immune adjustment, and their clinical relevance warrants further investigation.

Read at publisher →

Similar articles